 TEL AVIV, Israel and BETHESDA, Md., Oct. 19, 2021 PRNewswire -- Cannabics Pharmaceuticals Inc. OTC: CNBX, a global leader in the development of cancer related cannabinoid-based medicine, announced today that Company CEO, Eyal Barad, will present at the upcoming Edison Open Forum: Cannabinoids 2021, taking place today, Wednesday, October 19 th. 